ID   DUS6_HUMAN              Reviewed;         381 AA.
AC   Q16828; O75109; Q53Y75; Q9BSH6;
DT   01-NOV-1997, integrated into UniProtKB/Swiss-Prot.
DT   30-MAY-2006, sequence version 2.
DT   12-APR-2017, entry version 174.
DE   RecName: Full=Dual specificity protein phosphatase 6;
DE            EC=3.1.3.16;
DE            EC=3.1.3.48;
DE   AltName: Full=Dual specificity protein phosphatase PYST1;
DE   AltName: Full=Mitogen-activated protein kinase phosphatase 3;
DE            Short=MAP kinase phosphatase 3;
DE            Short=MKP-3;
GN   Name=DUSP6; Synonyms=MKP3, PYST1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, SUBCELLULAR
RP   LOCATION, AND VARIANT LEU-114.
RC   TISSUE=Foreskin;
RX   PubMed=8670865;
RA   Groom L.A., Sneddon A.A., Alessi D.R., Dowd S., Keyse S.M.;
RT   "Differential regulation of the MAP, SAP and RK/p38 kinases by Pyst1,
RT   a novel cytosolic dual-specificity phosphatase.";
RL   EMBO J. 15:3621-3632(1996).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA] (ISOFORMS 1 AND 2), AND
RP   VARIANT LEU-114.
RC   TISSUE=Liver;
RX   PubMed=9858808;
RA   Furukawa T., Yatsuoka T., Youssef E.M., Abe T., Yokoyama T.,
RA   Fukushige S., Soeda E., Hoshi M., Hayashi Y., Sunamura M., Kobari M.,
RA   Horii A.;
RT   "Genomic analysis of DUSP6, a dual specificity MAP kinase phosphatase,
RT   in pancreatic cancer.";
RL   Cytogenet. Cell Genet. 82:156-159(1998).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANT
RP   LEU-114.
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) system donor
RT   vector.";
RL   Submitted (MAY-2003) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Colon, Kidney, Skin, and Stomach;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   X-RAY CRYSTALLOGRAPHY (2.35 ANGSTROMS) OF 204-347, AND ACTIVE SITE.
RX   PubMed=10048930; DOI=10.1038/5861;
RA   Stewart A.E., Dowd S., Keyse S.M., McDonald N.Q.;
RT   "Crystal structure of the MAPK phosphatase Pyst1 catalytic domain and
RT   implications for regulated activation.";
RL   Nat. Struct. Biol. 6:174-181(1999).
RN   [6]
RP   VARIANTS HH19 ILE-77; PHE-182; SER-189 AND MET-346.
RX   PubMed=23643382; DOI=10.1016/j.ajhg.2013.04.008;
RA   Miraoui H., Dwyer A.A., Sykiotis G.P., Plummer L., Chung W., Feng B.,
RA   Beenken A., Clarke J., Pers T.H., Dworzynski P., Keefe K.,
RA   Niedziela M., Raivio T., Crowley W.F. Jr., Seminara S.B., Quinton R.,
RA   Hughes V.A., Kumanov P., Young J., Yialamas M.A., Hall J.E.,
RA   Van Vliet G., Chanoine J.P., Rubenstein J., Mohammadi M., Tsai P.S.,
RA   Sidis Y., Lage K., Pitteloud N.;
RT   "Mutations in FGF17, IL17RD, DUSP6, SPRY4, and FLRT3 are identified in
RT   individuals with congenital hypogonadotropic hypogonadism.";
RL   Am. J. Hum. Genet. 92:725-743(2013).
CC   -!- FUNCTION: Inactivates MAP kinases. Has a specificity for the ERK
CC       family (PubMed:9858808). Plays an important role in alleviating
CC       chronic postoperative pain. Necessary for the normal
CC       dephosphorylation of the long-lasting phosphorylated forms of
CC       spinal MAPK1/3 and MAP kinase p38 induced by peripheral surgery,
CC       which drives the resolution of acute postoperative allodynia (By
CC       similarity). {ECO:0000250|UniProtKB:Q9DBB1,
CC       ECO:0000269|PubMed:8670865}.
CC   -!- CATALYTIC ACTIVITY: Protein tyrosine phosphate + H(2)O = protein
CC       tyrosine + phosphate.
CC   -!- CATALYTIC ACTIVITY: [a protein]-serine/threonine phosphate + H(2)O
CC       = [a protein]-serine/threonine + phosphate.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:8670865}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q16828-1; Sequence=Displayed;
CC       Name=2; Synonyms=DUSP6-ALT;
CC         IsoId=Q16828-2; Sequence=VSP_005137;
CC   -!- DISEASE: Hypogonadotropic hypogonadism 19 with or without anosmia
CC       (HH19) [MIM:615269]: A disorder characterized by absent or
CC       incomplete sexual maturation by the age of 18 years, in
CC       conjunction with low levels of circulating gonadotropins and
CC       testosterone and no other abnormalities of the hypothalamic-
CC       pituitary axis. In some cases, it is associated with non-
CC       reproductive phenotypes, such as anosmia, cleft palate, and
CC       sensorineural hearing loss. Anosmia or hyposmia is related to the
CC       absence or hypoplasia of the olfactory bulbs and tracts.
CC       Hypogonadism is due to deficiency in gonadotropin-releasing
CC       hormone and probably results from a failure of embryonic migration
CC       of gonadotropin-releasing hormone-synthesizing neurons. In the
CC       presence of anosmia, idiopathic hypogonadotropic hypogonadism is
CC       referred to as Kallmann syndrome, whereas in the presence of a
CC       normal sense of smell, it has been termed normosmic idiopathic
CC       hypogonadotropic hypogonadism (nIHH).
CC       {ECO:0000269|PubMed:23643382}. Note=The disease is caused by
CC       mutations affecting distinct genetic loci, including the gene
CC       represented in this entry. Some patients carrying mutations in
CC       DUSP6 also have a heterozygous mutation in another HH-associated
CC       gene including FGFR1 and SPRY4 (PubMed:23643382).
CC       {ECO:0000269|PubMed:23643382}.
CC   -!- SIMILARITY: Belongs to the protein-tyrosine phosphatase family.
CC       Non-receptor class dual specificity subfamily. {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology
CC       and Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/DUSP6ID46105ch12q21.html";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X93920; CAA63813.1; -; mRNA.
DR   EMBL; AB013601; BAA31968.1; -; Genomic_DNA.
DR   EMBL; AB013382; BAA34369.1; -; mRNA.
DR   EMBL; AB013602; BAA31969.1; -; mRNA.
DR   EMBL; BT006895; AAP35541.1; -; mRNA.
DR   EMBL; BC003143; AAH03143.1; -; mRNA.
DR   EMBL; BC003562; AAH03562.1; -; mRNA.
DR   EMBL; BC005047; AAH05047.1; -; mRNA.
DR   EMBL; BC037236; AAH37236.1; -; mRNA.
DR   CCDS; CCDS9033.1; -. [Q16828-1]
DR   CCDS; CCDS9034.1; -. [Q16828-2]
DR   RefSeq; NP_001937.2; NM_001946.3. [Q16828-1]
DR   RefSeq; NP_073143.2; NM_022652.3. [Q16828-2]
DR   UniGene; Hs.298654; -.
DR   UniGene; Hs.718640; -.
DR   PDB; 1HZM; NMR; -; A=1-154.
DR   PDB; 1MKP; X-ray; 2.35 A; A=205-347.
DR   PDBsum; 1HZM; -.
DR   PDBsum; 1MKP; -.
DR   ProteinModelPortal; Q16828; -.
DR   SMR; Q16828; -.
DR   BioGrid; 108181; 10.
DR   IntAct; Q16828; 6.
DR   MINT; MINT-1442837; -.
DR   STRING; 9606.ENSP00000279488; -.
DR   BindingDB; Q16828; -.
DR   ChEMBL; CHEMBL1250381; -.
DR   DEPOD; Q16828; -.
DR   iPTMnet; Q16828; -.
DR   PhosphoSitePlus; Q16828; -.
DR   BioMuta; DUSP6; -.
DR   DMDM; 108860971; -.
DR   EPD; Q16828; -.
DR   MaxQB; Q16828; -.
DR   PaxDb; Q16828; -.
DR   PeptideAtlas; Q16828; -.
DR   PRIDE; Q16828; -.
DR   DNASU; 1848; -.
DR   Ensembl; ENST00000279488; ENSP00000279488; ENSG00000139318. [Q16828-1]
DR   Ensembl; ENST00000308385; ENSP00000307835; ENSG00000139318. [Q16828-2]
DR   GeneID; 1848; -.
DR   KEGG; hsa:1848; -.
DR   UCSC; uc001tay.5; human. [Q16828-1]
DR   CTD; 1848; -.
DR   DisGeNET; 1848; -.
DR   GeneCards; DUSP6; -.
DR   HGNC; HGNC:3072; DUSP6.
DR   HPA; CAB017566; -.
DR   HPA; HPA053188; -.
DR   MalaCards; DUSP6; -.
DR   MIM; 602748; gene.
DR   MIM; 615269; phenotype.
DR   neXtProt; NX_Q16828; -.
DR   OpenTargets; ENSG00000139318; -.
DR   Orphanet; 478; Kallmann syndrome.
DR   Orphanet; 432; Normosmic congenital hypogonadotropic hypogonadism.
DR   PharmGKB; PA27529; -.
DR   eggNOG; KOG1717; Eukaryota.
DR   eggNOG; COG2453; LUCA.
DR   GeneTree; ENSGT00760000118902; -.
DR   HOGENOM; HOG000294079; -.
DR   HOVERGEN; HBG007347; -.
DR   InParanoid; Q16828; -.
DR   KO; K04459; -.
DR   OMA; RDWNENT; -.
DR   OrthoDB; EOG091G0249; -.
DR   PhylomeDB; Q16828; -.
DR   TreeFam; TF105122; -.
DR   BRENDA; 3.1.3.16; 2681.
DR   BRENDA; 3.1.3.48; 2681.
DR   Reactome; R-HSA-112409; RAF-independent MAPK1/3 activation.
DR   Reactome; R-HSA-202670; ERKs are inactivated.
DR   Reactome; R-HSA-5675221; Negative regulation of MAPK pathway.
DR   SignaLink; Q16828; -.
DR   SIGNOR; Q16828; -.
DR   ChiTaRS; DUSP6; human.
DR   EvolutionaryTrace; Q16828; -.
DR   GeneWiki; DUSP6; -.
DR   GenomeRNAi; 1848; -.
DR   PRO; PR:Q16828; -.
DR   Proteomes; UP000005640; Chromosome 12.
DR   Bgee; ENSG00000139318; -.
DR   CleanEx; HS_DUSP6; -.
DR   ExpressionAtlas; Q16828; baseline and differential.
DR   Genevisible; Q16828; HS.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0005654; C:nucleoplasm; TAS:Reactome.
DR   GO; GO:0017017; F:MAP kinase tyrosine/serine/threonine phosphatase activity; IDA:UniProtKB.
DR   GO; GO:0004725; F:protein tyrosine phosphatase activity; TAS:Reactome.
DR   GO; GO:0008138; F:protein tyrosine/serine/threonine phosphatase activity; TAS:Reactome.
DR   GO; GO:0000187; P:activation of MAPK activity; TAS:Reactome.
DR   GO; GO:0030154; P:cell differentiation; IEA:Ensembl.
DR   GO; GO:0009953; P:dorsal/ventral pattern formation; IBA:GO_Central.
DR   GO; GO:0000188; P:inactivation of MAPK activity; IDA:UniProtKB.
DR   GO; GO:0000165; P:MAPK cascade; TAS:Reactome.
DR   GO; GO:0070373; P:negative regulation of ERK1 and ERK2 cascade; IMP:UniProtKB.
DR   GO; GO:0035335; P:peptidyl-tyrosine dephosphorylation; IDA:UniProtKB.
DR   GO; GO:0043065; P:positive regulation of apoptotic process; IDA:UniProtKB.
DR   GO; GO:0042663; P:regulation of endodermal cell fate specification; IBA:GO_Central.
DR   GO; GO:0040036; P:regulation of fibroblast growth factor receptor signaling pathway; IBA:GO_Central.
DR   GO; GO:0060420; P:regulation of heart growth; IBA:GO_Central.
DR   GO; GO:0042493; P:response to drug; IEA:Ensembl.
DR   GO; GO:0070848; P:response to growth factor; IEA:Ensembl.
DR   GO; GO:0051409; P:response to nitrosative stress; IEP:UniProtKB.
DR   GO; GO:0014070; P:response to organic cyclic compound; IEA:Ensembl.
DR   CDD; cd00127; DSPc; 1.
DR   Gene3D; 3.40.250.10; -; 1.
DR   Gene3D; 3.90.190.10; -; 1.
DR   InterPro; IPR000340; Dual-sp_phosphatase_cat-dom.
DR   InterPro; IPR024950; DUSP.
DR   InterPro; IPR008343; MKP.
DR   InterPro; IPR029021; Prot-tyrosine_phosphatase-like.
DR   InterPro; IPR001763; Rhodanese-like_dom.
DR   InterPro; IPR000387; TYR_PHOSPHATASE_dom.
DR   InterPro; IPR020422; TYR_PHOSPHATASE_DUAL_dom.
DR   PANTHER; PTHR10159; PTHR10159; 1.
DR   Pfam; PF00782; DSPc; 1.
DR   Pfam; PF00581; Rhodanese; 1.
DR   PIRSF; PIRSF000939; MAPK_Ptase; 1.
DR   PRINTS; PR01764; MAPKPHPHTASE.
DR   SMART; SM00195; DSPc; 1.
DR   SMART; SM00450; RHOD; 1.
DR   SUPFAM; SSF52799; SSF52799; 1.
DR   SUPFAM; SSF52821; SSF52821; 1.
DR   PROSITE; PS50206; RHODANESE_3; 1.
DR   PROSITE; PS50056; TYR_PHOSPHATASE_2; 1.
DR   PROSITE; PS50054; TYR_PHOSPHATASE_DUAL; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Complete proteome; Cytoplasm;
KW   Disease mutation; Hydrolase; Hypogonadotropic hypogonadism;
KW   Kallmann syndrome; Polymorphism; Protein phosphatase;
KW   Reference proteome.
FT   CHAIN         1    381       Dual specificity protein phosphatase 6.
FT                                /FTId=PRO_0000094804.
FT   DOMAIN       30    148       Rhodanese. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00173}.
FT   DOMAIN      206    381       Tyrosine-protein phosphatase.
FT   ACT_SITE    293    293       Phosphocysteine intermediate.
FT                                {ECO:0000269|PubMed:10048930}.
FT   VAR_SEQ     134    279       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:9858808}.
FT                                /FTId=VSP_005137.
FT   VARIANT      77     77       F -> I (in HH19; dbSNP:rs587776978).
FT                                {ECO:0000269|PubMed:23643382}.
FT                                /FTId=VAR_069943.
FT   VARIANT     114    114       V -> L (in dbSNP:rs2279574).
FT                                {ECO:0000269|PubMed:8670865,
FT                                ECO:0000269|PubMed:9858808,
FT                                ECO:0000269|Ref.3}.
FT                                /FTId=VAR_015113.
FT   VARIANT     144    144       S -> A (in dbSNP:rs770087).
FT                                /FTId=VAR_051750.
FT   VARIANT     182    182       S -> F (in HH19; rare variant associated
FT                                with susceptibility to disease; the
FT                                patient carries a second mutation in the
FT                                HH-associated gene FGFR1;
FT                                dbSNP:rs139318648).
FT                                {ECO:0000269|PubMed:23643382}.
FT                                /FTId=VAR_069944.
FT   VARIANT     189    189       N -> S (in HH19; dbSNP:rs143946794).
FT                                {ECO:0000269|PubMed:23643382}.
FT                                /FTId=VAR_069945.
FT   VARIANT     313    313       N -> I (in dbSNP:rs12828557).
FT                                /FTId=VAR_051751.
FT   VARIANT     346    346       T -> M (in HH19; rare variant associated
FT                                with susceptibility to disease; the
FT                                patient carries a second variant in the
FT                                HH-associated gene SPRY4;
FT                                dbSNP:rs146089505).
FT                                {ECO:0000269|PubMed:23643382}.
FT                                /FTId=VAR_069946.
FT   STRAND        7     12       {ECO:0000244|PDB:1HZM}.
FT   STRAND       15     18       {ECO:0000244|PDB:1HZM}.
FT   HELIX        23     29       {ECO:0000244|PDB:1HZM}.
FT   STRAND       31     33       {ECO:0000244|PDB:1HZM}.
FT   STRAND       35     37       {ECO:0000244|PDB:1HZM}.
FT   HELIX        43     48       {ECO:0000244|PDB:1HZM}.
FT   STRAND       50     52       {ECO:0000244|PDB:1HZM}.
FT   HELIX        61     64       {ECO:0000244|PDB:1HZM}.
FT   TURN         73     76       {ECO:0000244|PDB:1HZM}.
FT   HELIX        81     88       {ECO:0000244|PDB:1HZM}.
FT   STRAND       95     97       {ECO:0000244|PDB:1HZM}.
FT   STRAND      101    105       {ECO:0000244|PDB:1HZM}.
FT   HELIX       114    124       {ECO:0000244|PDB:1HZM}.
FT   HELIX       136    143       {ECO:0000244|PDB:1HZM}.
FT   STRAND      149    152       {ECO:0000244|PDB:1HZM}.
FT   STRAND      208    211       {ECO:0000244|PDB:1MKP}.
FT   STRAND      214    217       {ECO:0000244|PDB:1MKP}.
FT   HELIX       225    230       {ECO:0000244|PDB:1MKP}.
FT   STRAND      233    238       {ECO:0000244|PDB:1MKP}.
FT   STRAND      246    250       {ECO:0000244|PDB:1MKP}.
FT   STRAND      253    257       {ECO:0000244|PDB:1MKP}.
FT   HELIX       269    271       {ECO:0000244|PDB:1MKP}.
FT   HELIX       272    284       {ECO:0000244|PDB:1MKP}.
FT   STRAND      288    292       {ECO:0000244|PDB:1MKP}.
FT   HELIX       298    312       {ECO:0000244|PDB:1MKP}.
FT   HELIX       316    326       {ECO:0000244|PDB:1MKP}.
FT   HELIX       337    345       {ECO:0000244|PDB:1MKP}.
SQ   SEQUENCE   381 AA;  42320 MW;  386612227F5D3B2A CRC64;
     MIDTLRPVPF ASEMAISKTV AWLNEQLELG NERLLLMDCR PQELYESSHI ESAINVAIPG
     IMLRRLQKGN LPVRALFTRG EDRDRFTRRC GTDTVVLYDE SSSDWNENTG GESVLGLLLK
     KLKDEGCRAF YLEGGFSKFQ AEFSLHCETN LDGSCSSSSP PLPVLGLGGL RISSDSSSDI
     ESDLDRDPNS ATDSDGSPLS NSQPSFPVEI LPFLYLGCAK DSTNLDVLEE FGIKYILNVT
     PNLPNLFENA GEFKYKQIPI SDHWSQNLSQ FFPEAISFID EARGKNCGVL VHCLAGISRS
     VTVTVAYLMQ KLNLSMNDAY DIVKMKKSNI SPNFNFMGQL LDFERTLGLS SPCDNRVPAQ
     QLYFTTPSNQ NVYQVDSLQS T
//
